Key Messages 1. Influenza vaccination of elderly people living in the community was cost-effective from a societal perspective but did not cut publicly funded medical costs or total medical costs. 2. For the oldest group (≥75 years) living in the community, influenza vaccination can cut publicly funded medical costs if the total vaccination cost per head is HK$39.6 or less. 3. Influenza vaccination is costeffective if the value of increasing an elderly person’s lifespan for a year at most is measured as HK$68 047 or more.published_or_final_versio
Influenza can cause significant morbidity and mortality. Influenza vaccination is an effective and s...
Influenza is a serious public health problem that circulates worldwide affecting every age group and...
Introduction: Influenza causes a significant burden among Australian adults aged 50–64, however, vac...
1. A cohort of Elderly Health Centres was examined to determine whether influenza vaccination decrea...
Background: To compare cost and quality-adjusted life-years (QALYs) gained by influenza vaccination ...
BACKGROUND: China has an aging population with an increasing number of adults aged ≥ 60 years. Influ...
Due to viral strains, influenza season, and consultations and admission rates varying from country t...
textabstractVaccination represents the single most cost-effective strategy to avert influenza-relate...
Most western countries have influenza vaccination programmes for citizens aged greater than or equal...
OBJECTIVES:Despite a high vaccine uptake rate of over 80% in South Korea, the disease burden of infl...
Objective: To determine the efficacy and cost-effectiveness of influenza vaccination in the Thai eld...
Background: Influenza epidemics are responsible for considerable mortality and morbidity rates, esp...
1. Influenza and pneumococcal vaccine uptake in older adults of Hong Kong has dramatically increased...
ObjectivesDespite a high vaccine uptake rate of over 80% in South Korea, the disease burden of influ...
BACKGROUND: The present study aims to evaluate the cost-effectiveness of extending the pre-2013 infl...
Influenza can cause significant morbidity and mortality. Influenza vaccination is an effective and s...
Influenza is a serious public health problem that circulates worldwide affecting every age group and...
Introduction: Influenza causes a significant burden among Australian adults aged 50–64, however, vac...
1. A cohort of Elderly Health Centres was examined to determine whether influenza vaccination decrea...
Background: To compare cost and quality-adjusted life-years (QALYs) gained by influenza vaccination ...
BACKGROUND: China has an aging population with an increasing number of adults aged ≥ 60 years. Influ...
Due to viral strains, influenza season, and consultations and admission rates varying from country t...
textabstractVaccination represents the single most cost-effective strategy to avert influenza-relate...
Most western countries have influenza vaccination programmes for citizens aged greater than or equal...
OBJECTIVES:Despite a high vaccine uptake rate of over 80% in South Korea, the disease burden of infl...
Objective: To determine the efficacy and cost-effectiveness of influenza vaccination in the Thai eld...
Background: Influenza epidemics are responsible for considerable mortality and morbidity rates, esp...
1. Influenza and pneumococcal vaccine uptake in older adults of Hong Kong has dramatically increased...
ObjectivesDespite a high vaccine uptake rate of over 80% in South Korea, the disease burden of influ...
BACKGROUND: The present study aims to evaluate the cost-effectiveness of extending the pre-2013 infl...
Influenza can cause significant morbidity and mortality. Influenza vaccination is an effective and s...
Influenza is a serious public health problem that circulates worldwide affecting every age group and...
Introduction: Influenza causes a significant burden among Australian adults aged 50–64, however, vac...